Blog

In draft guidance published today healthcare guidance body NICE has recommended the anti-blood clotting drug apixaban (Eliquis, Bristol-Myers Squibb and ...

[:content [\N \I \C \E \space \h \a \s \space \i \s \s \u \e \d \space \f \i \n \a \l \space \g \u \i \d \a \n \c \e \space \n \o \t \space \r \e \c \o \m \m \e \n \d \i \n \g \space \c \r \i \z \o \t \i \n \i \b \space \( \X \a \l \k \o \r \i \, \space \P \f \i \z \e \r \) \space \f \o \r \space \p \r \e \v \i \o \u \s \l \y \space \t \r \e \a \t \e \d \space \a \n \a \p \l \a \s \t \i \c \- \l \y \m \p \h \o \m \a \- \k \i \n \a \s \e \- \p \o \s \i \t \i \v \e \space \a \d \v \a \n \c \e \d \space \n \o \n \- \s \m \a \l \l \- \c \e \l \l \space \l \u \n \g \space \c \a \n \c \e \r \. \  \C \o \m \m \e \n \t \i \n \g \space \o \n \space \t \h \e " ..."]]

Takeda has seen its treatment for people with Crohn’s disease Entyvio rejected by NICE in an initial appraisal. ...

In draft guidance published today healthcare guidance body NICE has recommended simeprevir sodium (Olysio, Janssen) as a treatment option for ...

NHS England has agreed to invest a whopping £190 million this year in new treatments for hepatitis C, so that ...

[:content [\1 \space \M \a \y \space \2 \0 \1 \4 \space \- \  \W \h \a \t \space \s \h \o \u \l \d \space \t \h \e \space \b \a \l \a \n \c \e \space \b \e \space \b \e \t \w \e \e \n \space \g \e \t \t \i \n \g \space \t \h \e \space \m \o \s \t \space \o \u \t \space \o \f \space \e \v \e \r \y \space \p \o \u \n \d \space \a \v \a \i \l \a \b \l \e \space \w \h \i \l \s \t \space \e \n \s \u \r \i \n \g \space \t \h \a \t " ..."]]

The National Institute for Health and Care Excellence has published final guidance recommending the use of Gilead’s Sovaldi (sofosbuvir), as ...

Patients with hepatitis C will now be able to access Janssen’s Olysio (simeprevir sodium) on the National Health Service in ...

NICE is consulting on its provisional recommendations on a treatment for Dupuytren’s contracture, where fingers gradually bend in towards the ...

The government’s Cancer Drugs Fund ‘makes no sense’ the head of the NHS drugs rationing body has said. ...

NICE has issued final draft guidance recommending lenalidomide (also known as Revlimid and marketed by Celgene) as an option, for ...

[:content [\1 \4 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \space \T \h \e \space \E \a \r \l \y \space \A \c \c \e \s \s \space \t \o \space \M \e \d \i \c \i \n \e \s \space \S \c \h \e \m \e \space \( \E \A \M \S \) \space \a \i \m \s \space \t \o \space \g \i \v \e \space \p \a \t \i \e \n \t \s \space \w \i \t \h \space \l \i \f \e \space \t \h \r \e \a \t \e \n \i \n \g \space \o \r \space \s \e \r \i \o \u \s \l \y " ..."]]

Patients with Crohn’s disease are now likely to get National Health Service access to Takeda’s biologic Entyvio in England and ...

[:content [\N \I \C \E \space \h \a \s \space \i \s \s \u \e \d \  \f \i \n \a \l \space \d \r \a \f \t \space \g \u \i \d \a \n \c \e \space \f \o \r \space \c \r \i \z \o \t \i \n \i \b \space \( \X \a \l \k \o \r \i \) \  \f \o \r \space \p \a \t \i \e \n \t \s \space \w \i \t \h \  \p \r \e \v \i \o \u \s \l \y \space \t \r \e \a \t \e \d \space \a \n \a \p \l \a \s \t \i \c \- \l \y \m \p \h \o \m \a \- \k \i \n \a \s \e \- \p \o \s \i \t \i \v \e \space \a \d \v \a \n \c \e \d \space \n \o \n \- \s \m \a \l \l \- \c \e \l \l \space \l \u \n \g \space \c \a \n \c \e \r \. \space \T \h \e \space \d \r \a \f \t \space \g \u \i \d \a \n \c \e \space \d \o \e \s " ..."]]